Skip to Main Content
Contribute Try STAT+ Today

Several advocacy groups petitioned the Centers for Disease Control and Prevention to stop making claims that it does not accept commercial support or have financial relationships with drug makers and other companies that may benefit from agency research.

In arguing their case, the groups contend that disclaimers appear in various CDC publications, even though the agency has actually accepted tens of millions of dollars of commercial support through the National Foundation for the Centers for Disease Control and Prevention. The nonprofit, which was created by Congress to generate private sector support for the agency’s work, was launched in 1995.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.